Extends "Epinephrine Access and Emergency Treatment Act" to include administration of epinephrine auto-injector devices by individuals in possession of devices pursuant to personal prescriptions.
This bill (A3067) amends New Jersey's "Epinephrine Access and Emergency Treatment Act" to allow any person who possesses an epinephrine auto-injector device under a valid personal prescription (or for their minor child) to administer it to someone experiencing anaphylaxis or another serious condition treatable with epinephrine. It directly affects individuals with such prescriptions, including parents or guardians of children with allergies. The key provision expands the current law - which previously required certification - to permit immediate emergency use by prescription holders without needing prior training. The bill also adds liability protection for these individuals acting in good faith during emergencies, aligning with the existing protections for certified administrators.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024
Last action Jan 9, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Health Committee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Don Guardian
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about A 3067
Scope: NJ
Hi! I can help you understand A 3067. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline